US 7582736
Prostate cancer specific internalizing human antibodies
granted A61KA61K2039/505A61P
Quick answer
US patent 7582736 (Prostate cancer specific internalizing human antibodies) held by The Regents of the University of California expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00